Latest filings (excl ownership)
D
$15.00 mm in equity / options / securities to be acquired, sold $11.14 mm, 172 investors
22 Apr 24
S-3
Shelf registration
19 Apr 24
8-K
Other Events
18 Apr 24
8-K
Other Events
16 Apr 24
8-K
Unregistered Sales of Equity Securities
15 Apr 24
S-8
Registration of securities for employees
12 Apr 24
8-K
RenovoRx Announces $11.1 Million At Market Private Placement
9 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Departure of Directors or Certain Officers
14 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Feb 24
8-K
Departure of Directors or Certain Officers
9 Feb 24
D
Exempt offering of security
9 Feb 24
8-K
RenovoRx Closes $6.1 Million Private Placement
29 Jan 24
8-K
Other Events
2 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
18 Dec 23
DEF 14A
Definitive proxy
27 Nov 23
PRE 14A
Preliminary proxy
17 Nov 23
8-K
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Other Events
6 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
8 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Aug 23
8-K
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
17 Aug 23
10-Q
2023 Q2
Quarterly report
16 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
8-K
Other Events
29 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
EFFECT
Notice of effectiveness
22 May 23
424B3
Prospectus supplement
19 May 23
CORRESP
Correspondence with SEC
17 May 23
UPLOAD
Letter from SEC
16 May 23
8-K
RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
15 May 23
S-3
Shelf registration
12 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
DEF 14A
Definitive proxy
1 May 23
8-K
Departure of Directors or Certain Officers
27 Apr 23
8-K
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
3 Apr 23
424B5
Prospectus supplement for primary offering
3 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 23
S-8
Registration of securities for employees
31 Mar 23
Latest ownership filings
4
Leesa Gentry
8 Mar 24
3
Leesa Gentry
8 Mar 24
4
Ron Kocak
12 Feb 24
3
Ron Kocak
12 Feb 24
4
Ramtin Agah
30 Jan 24
4
Robert J. Spiegel
30 Jan 24
4
Shaun Bagai
30 Jan 24
4
Laurence Marton
30 Jan 24
4
K. Angela Macfarlane
30 Jan 24
4
Angela Nelms
23 Jan 24
4
Ramtin Agah
23 Jan 24
4
Shaun Bagai
23 Jan 24
4
Angela Nelms
4 Oct 23
4
Robert J. Spiegel
2 Oct 23
4
Laurence Marton
2 Oct 23
4
UNA S RYAN
2 Oct 23
4
David Diamond
2 Oct 23
4
K. Angela Macfarlane
2 Oct 23
4
Robert J. Spiegel
27 Apr 23
3
Robert J. Spiegel
27 Apr 23
4
Ramtin Agah
29 Mar 23
4
Shaun Bagai
29 Mar 23
4
Angela Nelms
29 Mar 23
SC 13G/A
Agah Ramtin
14 Feb 23
4
Laurence Marton
4 Nov 22
4
UNA S RYAN
4 Oct 22
4
Laurence Marton
4 Oct 22
4
K. Angela Macfarlane
4 Oct 22
4
David Diamond
4 Oct 22
4
Angela Nelms
21 Sep 22
3
Angela Nelms
21 Sep 22
3
James M Ahlers
20 Jul 22
4
Ramtin Agah
17 Jun 22
3/A
Ramtin Agah
17 Jun 22
4
Ramtin Agah
9 Jun 22
4
Shaun Bagai
23 May 22
3
OF THE WEST BANK
14 Apr 22
SC 13G
BANK OF THE WEST
14 Apr 22
4
UNA S RYAN
14 Mar 22
4
Laurence Marton
14 Mar 22